Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.54
-0.9%		$0.62
$0.43
▼
$2.04
$10.01M-2.7113,089 shs92,918 shs
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.22
+4.3%		$1.15
$1.00
▼
$5.50
$13.78M1.63147,298 shs177,373 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$8.11
+2.3%		$6.47
$3.75
▼
$9.40
$36.10M1.4921,874 shs32,325 shs
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
$10.85
-0.4%		$10.79
$10.19
▼
$11.45
$54.54MN/A610 shs273 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-0.93%-4.82%-3.59%-30.51%-55.78%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
+4.27%0.00%+14.02%-3.17%-67.64%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+2.27%+7.42%+32.95%+25.54%+63.84%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
-0.38%-0.01%+0.84%+0.78%+2.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.54
-0.9%		$0.62
$0.43
▼
$2.04
$10.01M-2.7113,089 shs92,918 shs
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.22
+4.3%		$1.15
$1.00
▼
$5.50
$13.78M1.63147,298 shs177,373 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$8.11
+2.3%		$6.47
$3.75
▼
$9.40
$36.10M1.4921,874 shs32,325 shs
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
$10.85
-0.4%		$10.79
$10.19
▼
$11.45
$54.54MN/A610 shs273 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-0.93%-4.82%-3.59%-30.51%-55.78%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
+4.27%0.00%+14.02%-3.17%-67.64%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+2.27%+7.42%+32.95%+25.54%+63.84%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
-0.38%-0.01%+0.84%+0.78%+2.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
1.50
ReduceN/AN/A
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.00
Hold$6.00391.80% Upside
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$6.75-16.77% Downside
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BNGO, IBAC, HBIO, and BFRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
8/18/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
8/14/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/14/2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D+)
8/12/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSpeculative Buy$6.00 ➝ $7.50
8/3/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/29/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/26/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
6/24/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 9/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$120K82.67N/AN/A$0.19 per share2.82
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$28.51M0.50N/AN/A$4.37 per share0.28
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$86.55M0.43$11.93 per share0.68$3.07 per share2.64
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.50M-$0.46N/AN/AN/AN/A-150.36%-127.98%11/13/2026 (Estimated)
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$26.40M-$3.02N/AN/AN/A-106.58%-78.78%-48.54%10/29/2026 (Estimated)
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$56.70M-$2.31N/AN/AN/A-11.86%-33.13%-4.80%11/5/2026 (Estimated)
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest BNGO, IBAC, HBIO, and BFRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$0.11-$0.07+$0.04-$0.07$0.22 million$0.22 million
8/11/2026Q2 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.21-$0.14+$0.07-$0.64$21.45 million$22.73 million
8/10/2026Q2 2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$0.67-$0.64+$0.03-$0.64$7.55 million($6.67) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
10.57
10.57
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.11
2.48
1.96
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4.94
1.87
0.98
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A

Insider Ownership

CompanyInsider Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
14.70%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.65%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
17.03%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
418.54 million15.82 millionNot Optionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
30011.78 million11.70 millionNo Data
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4904.55 million3.78 millionNo Data
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A5.01 millionN/AN/A

Recent News About These Companies

IB Acquisition Corp. (NASDAQ:IBAC) Short Interest Down 86.8% in July
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/ib-acquisition-corp-nasdaqibac-short-interest-down-868-in-july-2026-08-12/
IBAC IB Acquisition Corp.
July 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/IBAC/sec-filings
IB Acquisition Corp. Common Stock (IBAC) SEC Filings
July 10, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ibac/sec-filings
IB Acquisition Corp.
June 12, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/ibac/stock-grader
IB Acquisition Corp. Common Stock (IBAC) Institutional Holdings
April 11, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ibac/institutional-holdings
IB Acquisition Extends Business Combination Deadline to September 2026
March 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ib-acquisition-extends-business-combination-deadline-to-september-2026?utm_source=marketbeat.com&utm_medium=referral
IB Acquisition (NASDAQ:IBAC) Major Shareholder Aqr Capital Management Holding Sells 4,619 Shares
March 26, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2026-03-26/
Major Institutional Investor Makes Notable Move in IB Acquisition Corp. Stock
March 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/insider-trading/major-institutional-investor-makes-notable-move-in-ib-acquisition-corp-stock-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
IB Acquisition (NASDAQ:IBAC) Shares Down 0.2% – Here’s What Happened
March 4, 2026  |  defenseworld.netD
With 65% institutional ownership, IB Acquisition Corp. (NASDAQ:IBAC) is a favorite amongst the big guns
November 1, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/65-institutional-ownership-ib-acquisition-133051116.html
IB Acquisition (NASDAQ:IBAC) Major Shareholder Aqr Capital Management Holding Sells 195,806 Shares
October 15, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2025-10-15/
IB Acquisition (NASDAQ:IBAC) Major Shareholder Sells $1,284,244.50 in Stock
October 2, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2025-10-02/
IB Acquisition Corp. Extends Business Combination Deadline
September 25, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/ib-acquisition-corp-extends-business-combination-deadline/ar-AA1NhKj9
IB Acquisition (NASDAQ:IBAC) Sees Minor Dip Amid Low Volume Nasdaq Composite
June 27, 2025  |  kalkinemedia.comK
IB Acquisition Corp. - Right Stock Price, Quotes and Forecasts | NASDAQ:IBACR | Benzinga
April 10, 2025  |  benzinga.comhttps://www.benzinga.com/quote/IBACR
IB Acquisition Corp. Rt
March 27, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/IBACR/financials/annual/balance-sheet
Trading (IBAC) With Integrated Risk Controls
January 1, 2025  |  news.stocktradersdaily.comN
SGI CANADA renews support for key IBAC campaign
October 30, 2024  |  insurancebusinessmag.comI
Gore Mutual renews full backing for IBAC's Broker Identity Program
October 16, 2024  |  insurancebusinessmag.comI
IBAC unveils leadership and governance rosters
October 16, 2024  |  insurancebusinessmag.comI
IB Acquisition Corp. (IBAC)
October 13, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/IBAC/key-statistics/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$0.54 -0.01 (-0.93%)
Closing price 08/31/2026 04:00 PM Eastern
Extended Trading
$0.56 +0.02 (+3.72%)
As of 05:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$1.22 +0.05 (+4.27%)
Closing price 08/31/2026 04:00 PM Eastern
Extended Trading
$1.22 0.00 (0.00%)
As of 05:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$8.11 +0.18 (+2.27%)
As of 08/31/2026 04:00 PM Eastern

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

IB Acquisition stock logo

IB Acquisition NASDAQ:IBAC

$10.85 -0.04 (-0.38%)
As of 08/31/2026 11:07 AM Eastern
This is a fair market value price provided by Massive. Learn more.

IB Acquisition Corp. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. IB Acquisition Corp. is based in Boca Raton, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas